Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors

Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum

(2020) Divyanshu Dubey et al.   ANNALS OF NEUROLOGY

Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis

(2020) Lili Zhang et al.   EUROPEAN HEART JOURNAL

Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis

(2020) Magid Awadalla et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence

(2020) Raju K. Vaddepally et al.   Cancers

Comparison of ice-pack test and single fiber EMG diagnostic accuracy in patients referred for myasthenic ptosis

(2020) Maria Pia Giannoccaro et al.   NEUROLOGY

Central nervous system injury from novel cancer immunotherapies

(2020) Sebastian F. Winter et al.   CURRENT OPINION IN NEUROLOGY

Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm

(2020) Shahar Shelly et al.   NEUROLOGY

Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies

(2019) Annette Johansen et al.   NEUROLOGY

Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors

(2019) Francesc Graus et al.   Nature Reviews Clinical Oncology

Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

(2019) John A. Thompson et al.   Journal of the National Comprehensive Cancer Network

Inflammatory myopathy associated with PD-1 inhibitors

(2019) Morinobu Seki et al.   JOURNAL OF AUTOIMMUNITY

Neurotoxicity associated with cancer immunotherapy

(2019) Claire Perrinjaquet et al.   CURRENT OPINION IN NEUROLOGY

Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy

(2019) Xi Chen et al.   CLINICAL NEUROPHYSIOLOGY

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

(2019) Filipe Martins et al.   Nature Reviews Clinical Oncology

Risk of Neurological Toxicities Following the Use of Different Immune Checkpoint Inhibitor Regimens in Solid Tumors

(2019) Min Xu et al.   NEUROLOGIST

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

(2019) Douglas B. Johnson et al.   Journal for ImmunoTherapy of Cancer

Advances in cancer immunotherapy 2019 – latest trends

(2019) Stephan Kruger et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Immune Checkpoint Inhibitor Toxicities

(2019) Julian A. Marin-Acevedo et al.   MAYO CLINIC PROCEEDINGS

Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy

(2019) Anastasia Zekeridou et al.   MAYO CLINIC PROCEEDINGS

Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom control

(2019) Michael S. Hughes et al.   Cancer Medicine

Immuno-oncology drug development goes global

(2019) Jia Xin Yu et al.   NATURE REVIEWS DRUG DISCOVERY

Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies

(2019) Divyanshu Dubey et al.   NEUROLOGY

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4

(2019) Shuang Qin et al.   Molecular Cancer

Trends in clinical development for PD-1/PD-L1 inhibitors

(2019) Jia Xin Yu et al.   NATURE REVIEWS DRUG DISCOVERY

Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition

(2019) Peter Chei-way Pan et al.   Current Oncology Reports

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature

(2019) Houssein Safa et al.   Journal for ImmunoTherapy of Cancer

Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient

(2019) Vincent Pillonel et al.   Journal for ImmunoTherapy of Cancer

Vasculitis associated with immune checkpoint inhibitors—a systematic review

(2018) Anisha Daxini et al.   CLINICAL RHEUMATOLOGY

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

(2018) Julie R. Brahmer et al.   JOURNAL OF CLINICAL ONCOLOGY

PD-1 Inhibitor-associated Myopathies

(2018) Teerin Liewluck et al.   JOURNAL OF IMMUNOTHERAPY

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

(2018) Mehdi Touat et al.   NEUROLOGY

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis

(2018) Barney J. Stern et al.   JAMA Neurology

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

(2018) Daniel Y. Wang et al.   JAMA Oncology

Novel methods to diagnose leptomeningeal metastases in breast cancer

(2018) Lindsay Angus et al.   NEURO-ONCOLOGY

Diagnosis and Management of Immune Checkpoint Inhibitor‐Associated Neurologic Toxicity: Illustrative Case and Review of the Literature

(2018) Kerry L. Reynolds et al.   ONCOLOGIST

Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature

(2017) S. Cuzzubbo et al.   EUROPEAN JOURNAL OF CANCER

Pembrolizumab-Induced Encephalopathy: A Review of Neurological Toxicities with Immune Checkpoint Inhibitors

(2017) Sophie Feng et al.   Journal of Thoracic Oncology

Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan

(2017) Shigeaki Suzuki et al.   NEUROLOGY

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

(2017) I. Puzanov et al.   Journal for ImmunoTherapy of Cancer

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis

(2016) Lisa Ann Gerdes et al.   ANNALS OF NEUROLOGY

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

(2016) Rita Nanda et al.   JOURNAL OF CLINICAL ONCOLOGY

CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment

(2016) Yonghao Cao et al.   NEUROLOGY

Autoantibody-Associated Central Nervous System Neurologic Disorders

(2016) Sean Pittock et al.   SEMINARS IN NEUROLOGY

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

(2015) Dean M. Wingerchuk et al.   NEUROLOGY

High-Resolution MRI Vessel Wall Imaging: Spatial and Temporal Patterns of Reversible Cerebral Vasoconstriction Syndrome and Central Nervous System Vasculitis

(2014) E. C. Obusez et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

(2012) J. C. Jennette et al.   ARTHRITIS AND RHEUMATISM

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE